Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:EDAP NASDAQ:NEPH NASDAQ:NNOX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$3.74-4.7%$3.64$1.14▼$4.50$156.38M1.35152,013 shs18,354 shsEDAPEdap Tms$4.09-2.0%$3.70$1.21▼$5.05$153.11M-0.157,311 shs3,003 shsNEPHNephros$2.99+1.4%$3.20$2.05▼$6.42$31.83M1.4741,298 shs6,377 shsNNOXNano-X Imaging$1.61-1.5%$2.29$1.59▼$5.86$111.69M1.191.26 million shs337,554 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+6.81%+28.10%-1.01%-1.51%+232.20%EDAPEdap Tms+0.97%+20.17%+26.36%-9.35%+87.84%NEPHNephros-16.19%-2.19%-0.34%-24.16%+55.26%NNOXNano-X Imaging-5.78%-5.78%-28.19%-31.51%-68.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$3.74-4.7%$3.64$1.14▼$4.50$156.38M1.35152,013 shs18,354 shsEDAPEdap Tms$4.09-2.0%$3.70$1.21▼$5.05$153.11M-0.157,311 shs3,003 shsNEPHNephros$2.99+1.4%$3.20$2.05▼$6.42$31.83M1.4741,298 shs6,377 shsNNOXNano-X Imaging$1.61-1.5%$2.29$1.59▼$5.86$111.69M1.191.26 million shs337,554 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+6.81%+28.10%-1.01%-1.51%+232.20%EDAPEdap Tms+0.97%+20.17%+26.36%-9.35%+87.84%NEPHNephros-16.19%-2.19%-0.34%-24.16%+55.26%NNOXNano-X Imaging-5.78%-5.78%-28.19%-31.51%-68.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate Buy$6.5074.03% UpsideEDAPEdap Tms 2.00Hold$6.0046.88% UpsideNEPHNephros 2.50Moderate Buy$6.00100.67% UpsideNNOXNano-X Imaging 2.83Moderate Buy$5.00211.53% UpsideCurrent Analyst Ratings BreakdownLatest NEPH, NNOX, EDAP, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026NEPHNephros Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)4/22/2026NNOXNano-X Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell4/21/2026NEPHNephros Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)4/20/2026NNOXNano-X Imaging D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/13/2026NNOXNano-X Imaging D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/10/2026NNOXNano-X Imaging Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/9/2026EDAPEdap Tms HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$14.00 ➝ $10.003/27/2026APYXApyx Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/11/2026APYXApyx Medical Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$5.00 ➝ $6.003/11/2026APYXApyx Medical BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$6.003/4/2026NNOXNano-X Imaging Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 5/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$52.84M2.96N/AN/A$0.39 per share9.58EDAPEdap Tms$70.53M2.17N/AN/A$0.52 per share7.86NEPHNephros$19.12M1.66$0.11 per share28.06$0.96 per share3.11NNOXNano-X Imaging$13.02M8.58N/AN/A$2.01 per share0.80Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$11.21M-$0.22N/AN/AN/A-16.40%-88.47%-14.94%N/AEDAPEdap Tms-$29.25M-$0.81N/AN/AN/A-41.47%-137.61%-40.62%N/ANEPHNephros$1.19M$0.0742.72N/AN/A4.06%7.66%5.86%N/ANNOXNano-X Imaging-$75.02M-$1.59N/AN/AN/A-790.87%-64.65%-57.27%7/20/2026 (Estimated)Latest NEPH, NNOX, EDAP, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026APYXApyx Medical-$0.11-$0.05+$0.06-$0.05$10.53 million$12.49 million5/7/2026Q1 2026EDAPEdap Tms-$0.22-$0.24-$0.02-$0.24$19.46 million$20.48 million5/7/2026Q1 2026NEPHNephros$0.01$0.01N/A$0.01$5.02 million$5.21 million4/20/2026Q4 2025NNOXNano-X Imaging-$0.15-$0.50-$0.35-$0.50$3.99 million$3.72 million3/26/2026Q4 2025EDAPEdap Tms-$0.16-$0.25-$0.09-$0.26$21.28 million$22.22 million3/12/2026Q4 2025NEPHNephros$0.01$0.01N/A$0.01$4.45 million$4.73 million3/10/2026Q4 2025APYXApyx Medical-$0.06-$0.03+$0.03-$0.03$19.12 million$19.16 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AEDAPEdap TmsN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/ANNOXNano-X ImagingN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical2.685.804.79EDAPEdap Tms1.791.340.99NEPHNephrosN/A4.553.12NNOXNano-X ImagingN/A3.963.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%EDAPEdap Tms62.74%NEPHNephros41.10%NNOXNano-X Imaging21.49%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%EDAPEdap Tms0.23%NEPHNephros6.70%NNOXNano-X ImagingN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27041.87 million35.51 millionOptionableEDAPEdap Tms23037.48 million37.40 millionOptionableNEPHNephros3010.64 million10.13 millionNot OptionableNNOXNano-X Imaging19069.59 millionN/AOptionableNEPH, NNOX, EDAP, and APYX HeadlinesRecent News About These CompaniesNano-X Imaging (NNOX) Builds Commercial Momentum With Multi-Year Nanox.ARC Deployment DealsMay 12 at 3:51 AM | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOXMay 7, 2026 | prnewswire.comNNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.May 5, 2026 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders Nano-X Imaging Ltd. (NASDAQ: NNOX)May 4, 2026 | globenewswire.comNanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC SystemsMay 4, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOXApril 30, 2026 | prnewswire.comNNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.April 29, 2026 | businesswire.comNNOX SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential ...April 29, 2026 | bakersfield.comBHow The Evolving Narrative Is Reshaping Nano-X Imaging (NNOX) Valuation ExpectationsApril 29, 2026 | finance.yahoo.comNano-X Imaging (NNOX) price target decreased by 10.14% to 6.78April 29, 2026 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOXApril 28, 2026 | globenewswire.comNNOX SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsApril 27, 2026 | globenewswire.comNNOX Investors Have Opportunity to Join Nano-X Imaging Ltd. Fraud Investigation with the Schall ...April 27, 2026 | caledonianrecord.comCNNOX Investors Have Opportunity to Join Nano-X Imaging Ltd. Fraud Investigation with the Schall Law FirmApril 26, 2026 | globenewswire.comNano-X Imaging Ltd. (NASDAQ:NNOX) Receives Average Rating of "Moderate Buy" from AnalystsApril 24, 2026 | marketbeat.comNano-X Imaging (NASDAQ:NNOX) Downgraded by Zacks Research to "Strong Sell"April 24, 2026 | marketbeat.comNANO-X INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Nano-X Imaging Ltd.April 23, 2026 | globenewswire.comGrowth Deal Meets Restructuring As Nano-X Eyes Margin ImprovementApril 22, 2026 | benzinga.comNano-X falls after Q4 miss, CFO transitionApril 22, 2026 | msn.comNano X Imaging Ltd (NNOX) Q4 2025 Earnings Call Highlights: Strategic Agreements and Financial ...April 22, 2026 | finance.yahoo.comNano-X Imaging Ltd. (NASDAQ:NNOX) Q4 2025 Earnings Call TranscriptApril 21, 2026 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNEPH, NNOX, EDAP, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$3.74 -0.19 (-4.72%) As of 11:01 AM Eastern This is a fair market value price provided by Massive. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Edap Tms NASDAQ:EDAP$4.08 -0.09 (-2.04%) As of 11:03 AM Eastern This is a fair market value price provided by Massive. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.Nephros NASDAQ:NEPH$2.99 +0.04 (+1.36%) As of 10:59 AM Eastern This is a fair market value price provided by Massive. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.Nano-X Imaging NASDAQ:NNOX$1.60 -0.03 (-1.53%) As of 11:05 AM Eastern This is a fair market value price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Sony's $4 Billion Bet on Rock & Roll Royalties Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It AI Demand Fuels Strong Q1 Earnings for Constellation Energy TMC Forges a New EV Supply Chain at the Bottom of the Sea MercadoLibre Boldly Invests in Growth: Discount Deepens Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader 5 Stocks Positioned to Benefit From the AI Inference Boom Sell in May and Go Away—Starting With These 3 Stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
